title: Binding of [125I]iodipine to parathyroid cell membranes: evidence of a dihydropyridine-sensitive calcium channel.
abstract: The parathyroid cell is unusual, in that an increase in extracellular calcium concentrations inhibits PTH release. Calcium channels are glycoproteins that span cell membranes and allow entry of extracellular calcium into cells. We have demonstrated that the calcium channel agonist (+)202-791, which opens calcium channels, inhibits PTH release and that the antagonist (-)202-791, which closes calcium channels, stimulates PTH release. To identify the calcium channels responsible for these effects, we used a radioligand that specifically binds to calcium channels. Bovine parathyroid cell membranes were prepared and incubated under reduced lighting with [125I] iodipine (SA, 2000 Ci/mmol), which recognizes 1,4-dihydropyridine-sensitive calcium channels. Bound ligand was separated from free ligand by rapid filtration through Whatman GF/B filters. Nonspecific binding was measured by the inclusion of nifedipine at 10 microM. Specific binding represented approximately 40% of the total binding. The optimal temperature for [125I] iodipine binding was 4 C, and binding reached equilibrium by 30 min. The equilibrium dissociation constant (Kd) was approximately 550 pM, and the maximum number of binding sites was 780 fmol/mg protein. Both the calcium channel agonist (+)202-791 and antagonist (-)202-791 competitively inhibited [125I] iodipine binding, with 50% inhibition concentrations of 20 and 300 nM, respectively. These data indicate the presence of dihydropyridine-sensitive calcium channels on parathyroid cell membranes.
authors.affiliation: Department of Medicine, University of Texas Health Science Center, San Antonio 78284.
authors.forename: J I
authors.initials: JI
authors.lastname: Jones
authors.forename: L A
authors.initials: LA
authors.lastname: Fitzpatrick
mesh_terms: D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015220:Calcium Channels / Q000187:drug effects*; D002462:Cell Membrane / Q000378:metabolism; D004095:Dihydropyridines / Q000494:pharmacology*; D007457:Iodine Radioisotopes; D007462:Iodobenzenes / Q000037:antagonists & inhibitors / Q000378:metabolism; D007700:Kinetics; D008024:Ligands; D009539:Nicotinic Acids / Q000494:pharmacology; D009543:Nifedipine / Q000494:pharmacology; D010069:Oxadiazoles; D010280:Parathyroid Glands / Q000378:metabolism* / Q000648:ultrastructure; D013237:Stereoisomerism
chemical_list: D002121:Calcium Channel Blockers; D015220:Calcium Channels; D004095:Dihydropyridines; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D008024:Ligands; D009539:Nicotinic Acids; D010069:Oxadiazoles; C049834:PN 202-791; C038806:1,4-dihydropyridine; C041028:iodipine; D009543:Nifedipine